Comment on CMS-2026-1255-0001
National Health Law ProgramSupportAdvocacy
Summary: The National Health Law Program (NHeLP) supports the proposed rule to increase transparency and accountability in prior authorization for prescription drugs. They urge HHS to strengthen reporting requirements, provide detailed notice of denials at the point of sale, and ensure that clinical criteria are based on generally accepted standards of care.
To whom it may concern,
On behalf of the National Health Law Program, I am submitting comments on the proposed rule regarding interoperability and prior authorization of prescription drugs. Thank you for your consideration of these comments.
Best regards,